News

Under the agreement which has been extended for a further three years, GlaxoSmithKline (GSK) and the TB Alliance jointly fund 15 to 25 fully dedicated scientists at GSK’s

Under the new agreement, Medicines for Malaria Venture (MMV) will provide funding for research to be performed at GlaxoSmithKline (GSK). Research will focus on macrolide antibiotics, based on

The FDA approval was based on results from a Phase III clinical study conducted with more than 600 patients that found once-daily Moxatag for 10 days was effective

The label will be revised to state that available data indicate that rosiglitazone may be associated with an increased risk of myocardial ischaemic events. It will also state

This approval represents initiation of the first clinical sites for the pivotal study and permits commencement of screening for suitable patients. This approval is claimed to be the

In 2006, Paradigm Medical resolved two suits filed by former employees via summary judgments in favor of the company. Paradigm Medical has resolved several class-action suits out of

This approval grants seven years of US market exclusivity to Mobius, once its new drug application is approved. Ed Timm, president of Mobius, said: “Orphan drug status is

Lansoprazole delayed-release capsules are generic version of Tap Pharmaceutical’s gastric-acid pump inhibitor, Prevacid (lansoprazole) delayed-release capsules. According to IMS sales data, the brand product had annual sales of

Under terms of the previously executed memorandum of understanding (MOU) with Seafarer, Organetix is required to contribute a minimum of $150,000 and a maximum of $600,000 to the